Evidence map›Paper›PMID 35835961›Full record

ArticleNature cancer2022

Starfish infers signatures of complex genomic rearrangements across human cancers.

Lisui Bao, Xiaoming Zhong, Yang Yang, Lixing Yang

Open access · greenAbstract read
In one paragraph

Article in Nature cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Panorama of Chromosomal Instability in Lung Cancer.medRxiv : the preprint server for health sciences · 2025
    Article
  4. Sc-TUSV-Ext: Single-Cell Clonal Lineage Inference from Single Nucleotide Variants, Copy Number Alterations, and Structural Variants.Journal of computational biology : a journal of computational molecular cell biology · 2025
    Article
  5. Article
  6. The landscape of structural variation in pediatric cancer.bioRxiv : the preprint server for biology · 2025
    Article
  7. Chromoanagenesis and Beyond: Catastrophic Events Shaping the Genome.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  8. Article
  9. A review on trends in development and translation of omics signatures in cancer.Computational and structural biotechnology journal · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Lisui BaoBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
Xiaoming ZhongBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
Yang YangBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
Lixing YangBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA. lixingyang@uchicago.edu.ORCID 0000-0001-9618-2117
University of Chicago · US

Funding

Structural variations and their impact in human cancerK22CA193848 · NCI · UNIVERSITY OF CHICAGO · PI YANG, LIXING · 2017 to 2019
$508k
NCI NIH HHS K22 CA193848
6 · The paper itself

Abstract

Complex genomic rearrangements (CGRs) are common in cancer and are known to form via two aberrant cellular structures-micronuclei and chromatin bridges. However, which of these mechanisms is more relevant to CGR formation in cancer and whether there are other undiscovered mechanisms remain unknown. Here we developed a computational algorithm, 'Starfish', to analyze 2,014 CGRs from 2,428 whole-genome-sequenced (WGS) tumors and discovered six CGR signatures based on their copy number and breakpoint patterns. Extensive benchmarking showed that our CGR signatures are highly accurate and biologically meaningful. Three signatures can be attributed to known biological processes-micronuclei- and chromatin-bridge-induced chromothripsis and circular extrachromosomal DNA. Over half of the CGRs belong to the remaining three signatures, not reported previously. A unique signature, which we named 'hourglass chromothripsis', with localized breakpoints and a low amount of DNA loss, is abundant in prostate cancer. Hourglass chromothripsis is associated with mutant SPOP, which may induce genome instability.

Indexed as

ChromothripsisNeoplasmsAnimalsChromatinDNAGenome, HumanGenomicsHumansMaleNuclear ProteinsRepressor ProteinsStarfishChromatinDNANuclear ProteinsRepressor ProteinsSPOP protein, human

Identifiers

PMID35835961
PMCPMC11077613
OpenAlexW4285386912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.